Acrivon Therapeutics Inc. (ACRV) NASDAQ
$7.11 0.65 (9.98%)
Market Cap: $143.49M
As of 03/28/24 03:59 PM EDT. Market closed.
Acrivon Therapeutics Inc. (ACRV)
NASDAQ
$7.11
0.65 (9.98%)
Market Cap: $143.49M
As of 03/28/24 03:59 PM EDT. Market closed.
acrivon therapeutics is a biotech company specializing in drug development through early clinical treatment success using our unique predictive biomarker approach. our technology platform is based on integrating drug-regulated, global proteomics with focused intact tissue digital imaging to develop drug-tailored biomarker signatures for prospective patient responder identification. the ... read more
acrivon therapeutics is a biotech company specializing in drug development through early clinical treatment success using our unique predictive biomarker approach. our technology platform is based on integrating drug-regulated, global proteomics with focused intact tissue digital imaging to develop drug-tailored biomarker signatures for prospective patient responder identification. the foundational science is based on proven, pathway-based methods linking active disease-driving mechanisms with the drug mechanism-of-action, to precisely match the therapy with patients who will benefit. our method is applicable across drug modalities read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Miller Mary | Chief Legal Officer | Feb 14, 2024 | Option Exercise | $3.40 | 217 | 738 | 40,451 | Feb 16, 2024, 05:14 PM |
Masson Kristina | EVP - Business Operations | Feb 14, 2024 | Option Exercise | $3.40 | 579 | 1,969 | 318,226 | Feb 16, 2024, 05:13 PM |
Holm-Jorgensen Rasmus | Chief Financial Officer | Feb 14, 2024 | Option Exercise | $3.40 | 434 | 1,476 | 27,626 | Feb 16, 2024, 05:12 PM |
Gamelin Erick | Chief Development Officer | Feb 14, 2024 | Option Exercise | $3.40 | 468 | 1,591 | 18,167 | Feb 16, 2024, 05:10 PM |
Devroe Eric | Chief Operating Officer | Feb 14, 2024 | Option Exercise | $3.40 | 723 | 2,458 | 59,710 | Feb 16, 2024, 05:08 PM |
Blume-Jensen Peter | President and CEO | Feb 14, 2024 | Option Exercise | $3.40 | 41,861 | 142,327 | 2,616,812 | Feb 16, 2024, 05:06 PM |
Miller Mary | Chief Legal Officer | Jan 17, 2024 | Option Exercise | $4.35 | 652 | 2,836 | 40,668 | Jan 19, 2024, 04:24 PM |
Miller Mary | Chief Legal Officer | Nov 14, 2023 | Option Exercise | $5.08 | 735 | 3,734 | 41,320 | Nov 16, 2023, 07:43 PM |
Masson Kristina | EVP - Business Operations | Nov 14, 2023 | Option Exercise | $5.08 | 1,900 | 9,652 | 318,805 | Nov 16, 2023, 07:42 PM |
Holm-Jorgensen Rasmus | Chief Financial Officer | Nov 14, 2023 | Option Exercise | $5.08 | 1,470 | 7,468 | 28,060 | Nov 16, 2023, 07:42 PM |
Gamelin Erick | Chief Medical Officer | Nov 14, 2023 | Option Exercise | $5.08 | 1,395 | 7,087 | 18,635 | Nov 16, 2023, 07:41 PM |
Devroe Eric | Chief Operating Officer | Nov 14, 2023 | Option Exercise | $5.08 | 2,450 | 12,446 | 60,433 | Nov 16, 2023, 07:41 PM |
Blume-Jensen Peter | President and CEO | Nov 14, 2023 | Option Exercise | $5.08 | 239,023 | 1,214,237 | 2,658,673 | Nov 16, 2023, 07:41 PM |
Miller Mary | Chief Legal Officer | Oct 17, 2023 | Option Exercise | $5.48 | 2,232 | 12,231 | 42,055 | Oct 19, 2023, 07:45 PM |
Chione Ltd | 10% Owner | Jun 26, 2023 | Sale | $12.93 | 16 | 207 | 3,848,632 | Jun 28, 2023, 03:47 PM |
Holm-Jorgensen Rasmus | Chief Financial Officer | Jun 16, 2023 | Option Exercise | $3.63 | 9,500 | 34,485 | 29,530 | Jun 20, 2023, 05:21 PM |
Chione Ltd | 10% Owner | Jun 15, 2023 | Sale | $12.14 | 2,056 | 24,960 | 3,848,648 | Jun 20, 2023, 05:15 PM |
Chione Ltd | 10% Owner | Jun 14, 2023 | Sale | $12.13 | 893 | 10,832 | 3,850,704 | Jun 14, 2023, 06:33 PM |
Chione Ltd | 10% Owner | Jun 13, 2023 | Sale | $12.30 | 3,000 | 36,900 | 3,851,597 | Jun 14, 2023, 06:33 PM |
Chione Ltd | 10% Owner | Jun 12, 2023 | Sale | $12.34 | 2,000 | 24,680 | 3,854,597 | Jun 14, 2023, 06:33 PM |
Devroe Eric | Chief Operating Officer | Jun 05, 2023 | Option Exercise | $1.04 | 9,225 | 9,594 | 62,883 | Jun 06, 2023, 04:15 PM |
Blume-Jensen Peter | President and CEO | May 31, 2023 | Option Exercise | $3.88 | 33,605 | 130,387 | 2,403,702 | Jun 01, 2023, 08:40 PM |
Chione Ltd | 10% Owner | Nov 17, 2022 | Buy | $12.50 | 400,000 | 5,000,000 | 3,856,597 | Nov 21, 2022, 06:26 PM |
RA CAPITAL MANAGEMENT, L.P. | Director | Nov 17, 2022 | Buy | $12.50 | 3,389,500 | 42,368,750 | 4,384,206 | Nov 21, 2022, 04:31 PM |
Owner | Relationship | Date | Value($) |
Miller Mary | Chief Legal Officer | 02/14/2024 | 738 |
Masson Kristina | EVP - Business Operations | 02/14/2024 | 1,969 |
Holm-Jorgensen Rasmus | Chief Financial Officer | 02/14/2024 | 1,476 |
Gamelin Erick | Chief Development Officer | 02/14/2024 | 1,591 |
Devroe Eric | Chief Operating Officer | 02/14/2024 | 2,458 |
Blume-Jensen Peter | President and CEO | 02/14/2024 | 142,327 |
Miller Mary | Chief Legal Officer | 01/17/2024 | 2,836 |
Miller Mary | Chief Legal Officer | 11/14/2023 | 3,734 |
Masson Kristina | EVP - Business Operations | 11/14/2023 | 9,652 |
Holm-Jorgensen Rasmus | Chief Financial Officer | 11/14/2023 | 7,468 |
Gamelin Erick | Chief Medical Officer | 11/14/2023 | 7,087 |
Devroe Eric | Chief Operating Officer | 11/14/2023 | 12,446 |
Blume-Jensen Peter | President and CEO | 11/14/2023 | 1,214,237 |
Miller Mary | Chief Legal Officer | 10/17/2023 | 12,231 |
Chione Ltd | 10% Owner | 06/26/2023 | 207 |
Holm-Jorgensen Rasmus | Chief Financial Officer | 06/16/2023 | 34,485 |
Chione Ltd | 10% Owner | 06/15/2023 | 24,960 |
Chione Ltd | 10% Owner | 06/14/2023 | 10,832 |
Chione Ltd | 10% Owner | 06/13/2023 | 36,900 |
Chione Ltd | 10% Owner | 06/12/2023 | 24,680 |
Devroe Eric | Chief Operating Officer | 06/05/2023 | 9,594 |
Blume-Jensen Peter | President and CEO | 05/31/2023 | 130,387 |
Chione Ltd | 10% Owner | 11/17/2022 | 5,000,000 |
RA CAPITAL MANAGEMENT, L.P. | Director | 11/17/2022 | 42,368,750 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 4,810,508 | 0.37% | No change | Other |
BLACKROCK INC. | 565,832 | 0.00007% | 7.01% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 189,200 | 0.0001% | -0.19% | Other |
UBS OCONNOR LLC | 93,443 | 0.03% | -11.01% | Value |
D. E. SHAW & CO., INC. | 31,939 | 0.00014% | -31.68% | Other |
Period of Report: 09/30/2023
10-K/10-Q Filings: View